[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Open Access Policy
Articles archive::
All Issues
Current Issue
For Authors::
Call for Papers
Submission Instruction
Submission Form
Copyright
Peer Review Policy
For Reviewers::
Reviewers Section
Registration::
Registration Information
Registration Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
Principles of Publication::
Indexing Sources::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE
..
Open Access 
..
..
:: Volume 7, Issue 3 (Military Caring Sciences 2020) ::
MCS 2020, 7(3): 252-260 Back to browse issues page
The Seroprevalence of Toxoplasma Gondii in Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Southwest Iran
Shahrzad Soltani1 , Sanaz Tavakoli2 , Mohammad Barati3 , Marzieh Pashmforosh4 , Masoud Foroutan * 2
1- Ph.D. in Medical Parasitology, Assistant Professor, Abadan Faculty of Medical Sciences, Abadan, Iran.
2- Ph.D. Student of Medical Parasitology, Parasitology and Mycology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
3- Ph.D. in Medical Parasitology, Assistant Professor, Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran.
4- Ph.D. in Pharmacology, Assistant Professor, Behbahan Faculty of Medical Sciences, Behbahan, Iran.
Abstract:   (2234 Views)
Introduction: Toxoplasma gondii is an obligate intracellular parasite, which causes toxoplasmosis in humans and many warm-blooded vertebrates.
Objective: The present study aimed to determine the prevalence of T. gondii in patients with type 2 diabetes mellitus (T2DM) and control individuals in the southwest of Iran.
Materials and Methods: In this case-control study, 80 patients with T2DM and 100 healthy individuals referred to Taleghani hospital in Abadan city during the winter season. Anti-T. gondii IgG antibody was measured in sera of participants using enzyme-linked immunosorbent assay (ELISA). A questionnaire containing some demographic information and risk factors related to T. gondii infection was completed by each participant. Results were analyzed using SPSS software 20. P <0.05 were considered as statistically significant.
Results: About 72.5% of patients with T2DM and 29% of healthy subjects were found to be positive for IgG antibody. The difference was statistically significant (P<0.001). Among the risk factors, contact with cats in both cases (P<0.001) and control groups (P=0.045) and source of drinking water in the control group (P=0.048) were significantly associated with T. gondii infection. No significant association was observed between age, gender, place of residence, educational level and consuming raw or undercooked meat with T. gondii (P>0.05).
Discussion and Conclusion: Considering the high prevalence of T. gondii in patients with T2DM compared to healthy individuals, more attention should be paid to this high-risk group. It is suggested that these patients routinely be tested for this parasite.
 
Keywords: Abadan, Diabetes, ELISA, Iran, Prevalence, Toxoplasma gondii.
Full-Text [PDF 377 kb]   (586 Downloads)    
Type of Study: Research | Subject: Special
Received: 2020/07/5 | Accepted: 2020/08/23 | Published: 2020/12/30
References
1. Dubey JP. The history of Toxoplasma gondii--the first 100 years. J Eukaryot Microbiol. 2008;55(6):467-75. [DOI]
2. Foroutan M, Fakhri Y, Riahi SM, Ebrahimpour S, Namroodi S, Taghipour A, et al. The global seroprevalence of Toxoplasma gondii in pigs: A systematic review and meta-analysis. Vet Parasitol. 2019;269:42-52. [DOI] [PubMed]
3. Foroutan M, Dalvand S, Daryani A, Ahmadpour E, Majidiani H, Khademvatan S, et al. Rolling up the pieces of a puzzle: A systematic review and meta-analysis of the prevalence of toxoplasmosis in Iran. Alexandria J Med. 2019;54(3):189-96. [DOI]
4. Rostami A, Riahi SM, Contopoulos-Ioannidis DG, Gamble HR, Fakhri Y, Shiadeh MN, et al. Acute Toxoplasma infection in pregnant women worldwide: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(10):e0007807. DOI: 10.1371/journal.pntd.0007807 PMID: 31609966 [DOI]
5. Foroutan-Rad M, Majidiani H, Dalvand S, Daryani A, Kooti W, Saki J, et al. Toxoplasmosis in Blood Donors: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2016;30(3):116-22. DOI: 10.1016/j.tmrv.2016.03.002 PMID: 27145927
6. Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour Shiadeh M, Danesh M, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(6):673-83. DOI: 10.1016/j.cmi.2020.01.008 PMID: 31972316
7. Wang Z, Liu H, Ma Z, Ma H, Li Z, Yang Z, et al. Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis. Frontiers in Microb. 2017;8. DOI: 10.3389/fmicb.2017.00389
8. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014;137:185-94. DOI: 10.1016/j.actatropica.2014.05.015 PMID: 24887263
9. Saki J, Tavakoli S, Pedram M. Seroprevalence and molecular evaluation of toxoplasmosis in children with cancer in Khuzestan province, Southwest of Iran. J Parasit Dis. 2017;41(4):947-51. DOI: 10.1007/s12639-017-0916-4 PMID: 29114124
10. Abdoli A, Barati M, Pirestani M, Dalimi A. Screening of toxoplasmosis in cancer patients: a concern. Trop Doct. 2019;49(1):31-4. DOI: 10.1177/0049475518801618 PMID: 30270766
11. Abdoli A, Barati M, Dalimi A, Pirestani M, Hoseini Shokouh S. Toxoplasmosis Among Patients with Immunocompromising Conditions: A Snapshot. J Archives in Military Med. 2016;4(4). DOI: 10.5812/jamm.41832
12. Saki J, Shafieenia S, Foroutan-Rad M. Seroprevalence of toxoplasmosis in diabetic pregnant women in southwestern of Iran. J Parasit Dis. 2016;40(4):1586-9. DOI: 10.1007/s12639-015-0735-4 PMID: 27876989
13. Majidiani H, Dalvand S, Daryani A, Galvan-Ramirez ML, Foroutan-Rad M. Is chronic toxoplasmosis a risk factor for diabetes mellitus? A systematic review and meta-analysis of case-control studies. Braz J Infect Dis. 2016;20(6):605-9. DOI: 10.1016/j.bjid.2016.09.002 PMID: 27768900
14. Sullivan WJ, Jr., Jeffers V. Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev. 2012;36(3):717-33. DOI: 10.1111/j.1574-6976.2011.00305.x PMID: 22091606
15. Prandota J. T. gondii Infection Acquired during Pregnancy and/or after Birth may be Responsible for Development of both Type 1 and 2 Diabetes Mellitus. J Diabetes & Metabolism. 2013;04(02). DOI: 10.4172/2155-6156.1000241
16. Shapira Y, Agmon-Levin N, Selmi C, Petrikova J, Barzilai O, Ram M, et al. Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun. 2012;39(1-2):112-6. DOI: 10.1016/j.jaut.2012.01.001 PMID: 22297145
17. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. DOI: 10.2337/diacare.27.5.1047 PMID: 15111519
18. Molan A, Nosaka K, Hunter M, Zhang J, Meng X, Song M, et al. First Age- and Gender-Matched Case-Control Study in Australia Examining the Possible Association between Toxoplasma gondii Infection and Type 2 Diabetes Mellitus: The Busselton Health Study. J Parasitol Res. 2020;2020:3142918. DOI: 10.1155/2020/3142918 PMID: 32257421
19. Jafari Modrek M, Saravani R, Mousavi M, Salimi Khorashad A, Piri M. Investigation of IgG and IgM Antibodies Against Toxoplasma gondii Among Diabetic Patients. International J Infec. 2015;2(3). DOI: 10.17795/iji27595
20. Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev. 2014;13(4-5):403-7. DOI: 10.1016/j.autrev.2014.01.020 PMID: 24424179
21. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813-23. DOI: 10.2337/diacare.27.3.813 PMID: 14988310
22. Li YX, Xin H, Zhang XY, Wei CY, Duan YH, Wang HF, et al. Toxoplasma gondii Infection in Diabetes Mellitus Patients in China: Seroprevalence, Risk Factors, and Case-Control Studies. Biomed Res Int. 2018;2018:4723739. DOI: 10.1155/2018/4723739 PMID: 30662909
23. Khalili M, Mahami-Oskouei M, Shahbazi A, Safaiyan A, Mohammadzadeh-Gheshlaghi N, Mahami-Oskouei L. The Correlation between Serum Levels of Anti-Toxoplasma gondii Antibodies and the Risk of Diabetes. Iran J Parasitol. 2018;13(4):637-42. PMID: 30697319
24. Han Y, Nie L, Ye X, Zhou Z, Huang S, Zeng C, et al. The association between Toxoplasma gondii infection and hypertensive disorders in T2DM patients: a case-control study in the Han Chinese population. Parasitol Res. 2018;117(3):689-95. DOI: 10.1007/s00436-017-5737-y PMID: 29349623
25. Alvarado-Esquivel C, Loera-Moncivais N, Hernandez-Tinoco J, Sanchez-Anguiano LF, Hernandez-Madrid G, Rabago-Sanchez E, et al. Lack of Association Between Toxoplasma gondii Infection and Diabetes Mellitus: A Matched Case-Control Study in a Mexican Population. J Clin Med Res. 2017;9(6):508-11. DOI: 10.14740/jocmr3029w PMID: 28496551
26. Shirbazou S, Delpisheh A, Mokhetari R, Tavakoli G. Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients. Iran Red Crescent Med J. 2013;15(8):701-3. DOI: 10.5812/ircmj.5303 PMID: 24578838
27. Soltani S, Foroutan M, Hezarian M, Afshari H, Kahvaz MS. Cutaneous leishmaniasis: an epidemiological study in southwest of Iran. J Parasit Dis. 2019;43(2):190-7. DOI: 10.1007/s12639-018-1073-0 PMID: 31263323
28. Ozcelik S, Alim M, Ozpinar N. Detection of Toxoplasma gondii infection among diabetic patients in Turkey. Clinical Epidemiology & Global Health. 2020;8(3):899-902. DOI: 10.1016/j.cegh.2020.02.020
29. Shamsinia S, Dalimi A, Pirestani M. Is Toxoplasmosis a risk factor in diabetic patients in Tehran? . Infect Epidemiol Microbiol. 2019;5(3):49-59.
30. Khalil M, Baothman M, Alserhan F, Almunyif A, Alsharbe G, Samaren H, et al. Prevalence of Toxoplasma gondii infection in diabeticpatients in makkah AL mukarramah, Saudi arabia. Trop Biomed. 2018;35(2):464-71.
31. Gokce C, Yazar S, Bayram F, Gundogan K, Yaman O, Sahin I. Anti-Toxoplasma gondii antibodies in type 2 diabetes. Natl Med J India. 2008;21(1):51. PMID: 18472707
32. Siyadatpanah A, Tabatabaie F, Oormazdi H, Meamar A, Razmjou E, Hadighi R, et al. Comparison of anti-Toxoplasma IgG and IgM antibodies determined by ELISA method in diabetic and non-diabetic individuals in west Mazandaran province, Iran, 2011-2012. Ann Biol Res. 2013;4(6):281-5.
33. Rahimi MT, Daryani A, Sarvi S, Shokri A, Ahmadpour E, Teshnizi SH, et al. Cats and Toxoplasma gondii: A systematic review and meta-analysis in Iran. Onderstepoort J Vet Res. 2015;82(1):e1-e10. DOI: 10.4102/ojvr.v82i1.823 PMID: 26017063
34. Soltani S, Foroutan M, Afshari H, Hezarian M, Kahvaz MS. Seroepidemiological evaluation of Toxoplasma gondii immunity among the general population in southwest of Iran. J Parasit Dis. 2018;42(4):636-42. DOI: 10.1007/s12639-018-1047-2 PMID: 30538365
35. Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi AS. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis. Acta Trop. 2016;158:160-9. DOI: 10.1016/j.actatropica.2016.03.003 PMID: 26952970
36. Belluco S, Mancin M, Conficoni D, Simonato G, Pietrobelli M, Ricci A. Investigating the Determinants of Toxoplasma gondii Prevalence in Meat: A Systematic Review and Meta-Regression. PLoS One. 2016;11(4):e0153856. DOI: 10.1371/journal.pone.0153856 PMID: 27082633
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Research code: 98114
Ethics code: IR.BHN.REC.1399.008

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Soltani S, Tavakoli S, Barati M, Pashmforosh M, Foroutan M. The Seroprevalence of Toxoplasma Gondii in Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Southwest Iran. MCS 2020; 7 (3) :252-260
URL: http://mcs.ajaums.ac.ir/article-1-399-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 3 (Military Caring Sciences 2020) Back to browse issues page
علوم مراقبتی نظامی Military Caring Sciences
Persian site map - English site map - Created in 0.05 seconds with 43 queries by YEKTAWEB 4645